OssDsign AB
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in Sweden, Germany, the United States, the United Kingdom, rest of Europe, and internationally. It offers OssDsign Catalyst, a nanosynthetic bone graft for dual bone formation pathways through fusion mass. The company was founded in 2011 and is headquartered in Uppsala, Sweden.
OssDsign AB (OSSD) - Net Assets
Latest net assets as of December 2025: Skr310.03 Million SEK
Based on the latest financial reports, OssDsign AB (OSSD) has net assets worth Skr310.03 Million SEK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr397.87 Million) and total liabilities (Skr87.84 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr310.03 Million |
| % of Total Assets | 77.92% |
| Annual Growth Rate | 30.75% |
| 5-Year Change | 18.01% |
| 10-Year Change | N/A |
| Growth Volatility | 69.42 |
OssDsign AB - Net Assets Trend (2016–2025)
This chart illustrates how OssDsign AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for OssDsign AB (2016–2025)
The table below shows the annual net assets of OssDsign AB from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr310.03 Million | +44.83% |
| 2024-12-31 | Skr214.06 Million | -14.76% |
| 2023-12-31 | Skr251.13 Million | +1.22% |
| 2022-12-31 | Skr248.11 Million | -5.56% |
| 2021-12-31 | Skr262.72 Million | +134.43% |
| 2020-12-31 | Skr112.07 Million | -17.16% |
| 2019-12-31 | Skr135.28 Million | +184.84% |
| 2018-12-31 | Skr47.49 Million | -5.81% |
| 2017-12-31 | Skr50.42 Million | +81.54% |
| 2016-12-31 | Skr27.77 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to OssDsign AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 59841580200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr6.91 Million | 2.23% |
| Other Components | Skr967.83 Million | 312.17% |
| Total Equity | Skr310.03 Million | 100.00% |
OssDsign AB Competitors by Market Cap
The table below lists competitors of OssDsign AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
APS Holdings Corporation
KQ:054620
|
$45.27 Million |
|
WIELTON S.A. ZY-20
F:2W1
|
$45.28 Million |
|
Horizon Space Acquisition II Corp. Units
NASDAQ:HSPTU
|
$45.29 Million |
|
ICD Co. Ltd
KQ:040910
|
$45.30 Million |
|
Atari S.A.
PA:ALATA
|
$45.24 Million |
|
SQLI SA
PA:SQI
|
$45.22 Million |
|
Ikegps Group Ltd
AU:IKE
|
$45.21 Million |
|
Jetway Information Co Ltd
TWO:6161
|
$45.21 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in OssDsign AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 214,062,000 to 310,031,000, a change of 95,969,000 (44.8%).
- Net loss of 50,988,000 reduced equity.
- New share issuances of 173,271,000 increased equity.
- Other comprehensive income decreased equity by 30,841,999.
- Other factors increased equity by 4,527,999.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr-50.99 Million | -16.45% |
| Share Issuances | Skr173.27 Million | +55.89% |
| Other Comprehensive Income | Skr-30.84 Million | -9.95% |
| Other Changes | Skr4.53 Million | +1.46% |
| Total Change | Skr- | 44.83% |
Book Value vs Market Value Analysis
This analysis compares OssDsign AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.44x to 2.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | Skr1.13 | Skr6.15 | x |
| 2017-12-31 | Skr2.15 | Skr6.15 | x |
| 2018-12-31 | Skr2.02 | Skr6.15 | x |
| 2019-12-31 | Skr6.62 | Skr6.15 | x |
| 2020-12-31 | Skr4.45 | Skr6.15 | x |
| 2021-12-31 | Skr5.43 | Skr6.15 | x |
| 2022-12-31 | Skr4.23 | Skr6.15 | x |
| 2023-12-31 | Skr3.06 | Skr6.15 | x |
| 2024-12-31 | Skr2.16 | Skr6.15 | x |
| 2025-12-31 | Skr2.81 | Skr6.15 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently OssDsign AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -16.45%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -28.30%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 1.28x
- Recent ROE (-16.45%) is above the historical average (-65.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -102.67% | -679.74% | 0.11x | 1.39x | Skr-31.29 Million |
| 2017 | -125.49% | -823.64% | 0.11x | 1.39x | Skr-68.31 Million |
| 2018 | -117.94% | -422.28% | 0.18x | 1.58x | Skr-60.76 Million |
| 2019 | -62.28% | -499.29% | 0.11x | 1.13x | Skr-97.77 Million |
| 2020 | -75.48% | -340.10% | 0.10x | 2.20x | Skr-95.80 Million |
| 2021 | -35.75% | -296.03% | 0.09x | 1.31x | Skr-120.19 Million |
| 2022 | -40.06% | -174.41% | 0.17x | 1.37x | Skr-124.20 Million |
| 2023 | -51.96% | -116.35% | 0.31x | 1.42x | Skr-155.61 Million |
| 2024 | -23.20% | -37.07% | 0.44x | 1.44x | Skr-71.06 Million |
| 2025 | -16.45% | -28.30% | 0.45x | 1.28x | Skr-81.99 Million |
Industry Comparison
This section compares OssDsign AB's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $75,200,026
- Average return on equity (ROE) among peers: -74.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| OssDsign AB (OSSD) | Skr310.03 Million | -102.67% | 0.28x | $45.27 Million |
| Acarix A/S (ACARIX) | $76.60 Million | -60.65% | 0.08x | $28.86 Million |
| Arcoma AB (ARCOMA) | $12.52 Million | -92.85% | 4.66x | $8.93 Million |
| Bactiguard Holding AB (publ) (BACTI-B) | $353.18 Million | -39.18% | 0.87x | $19.20 Million |
| CellaVision AB (CEVI) | $20.07 Million | 13.08% | 1.20x | $262.59 Million |
| Clinical Laserthermia Systems AB (publ) (CLS-B) | $65.69 Million | -72.50% | 0.20x | $13.78 Million |
| Chordate Medical Holding AB (CMH) | $38.95 Million | -55.88% | 0.13x | $17.64K |
| Coala Life Group AB (COALA) | $52.33 Million | -287.99% | 0.53x | $468.93K |
| C-Rad AB (publ) (CRAD-B) | $93.64 Million | 22.63% | 0.57x | $56.67 Million |
| Duearity AB (DEAR) | $-2.39 Million | 0.00% | 0.00x | $34.43K |
| Episurf Medical AB (publ) (EPIS-B) | $41.40 Million | -170.53% | 0.39x | $5.40 Million |